13. The regulatory code: In silico challenges
Computer models and AI bring new opportunities and challenges. Tina Morrison, former FDA leader in regulatory science, shares insights from 15+ years advancing their use in healthcare regulation.
Computer models and Artificial Intelligence (AI) present a new and not fully understood set of opportunities and challenges. To navigate this complex landscape, we turned to a leading innovator in the field: Tina Morrison. With over 15 years of experience at the Food and Drug Administration (FDA), Tina served as the Director of the Office of Regulatory Science and Innovation, leading the agency in the use of computer models in regulatory affairs.
Related media
Episode 10- With great power comes great responsibility
In silico medicine is reshaping healthcare through computer models, but trust and equity are key. Collaboration among scientists, clinicians, patients, and policymakers ensures this digital future serves everyone.
Discover more
Episode 9: Beating childhood cancer with in silico medicine
Childhood cancer remains a global challenge. In the 9th Code and Cure video, we explore how in silico models simulate tumour responses to chemotherapy, helping doctors tailor safer, more effective treatments.
Discover more
Episode 8: Digital hearts – The future of cardiovascular medicine
Heart disease is the leading cause of death worldwide. In silico medicine lets clinicians virtually test pacemakers and occluders, optimising device choice and enhancing surgical precision.
Discover more